Tema Oncology ETF (CANC) price, chart and fund profile
Price chart
Fund profile
CANC is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations.
- Issuer
- Tema Global Ltd.
- Industry
- Healthcare
- Inception
- Aug 14, 2023
- Assets under management
- $209.8M
- Expense ratio
- 0.75%
- Net asset value
- $43.34
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.temaetfs.com↗
Frequently asked questions
What is Tema Oncology ETF (CANC)?
CANC is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations.
What is CANC's expense ratio?
Tema Oncology ETF charges an annual expense ratio of 0.75%. The fund is issued by Tema Global Ltd..
How large is CANC?
Tema Oncology ETF manages $209.8M in assets and has traded since Aug 14, 2023.
How do I buy shares of Tema Oncology ETF (CANC)?
CANC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.